Novo Nordisk has rebounded strongly in 2025, backed by solid financials despite earlier setbacks and competitive risks. See ...

Novo Nordisk’s annual report contains an interesting footnote on its key drug, Ozempic, which last year accounted for $19 ...

Dilok Klaisataporn Most major stock indexes across the globe ended the week lower, following US-China trade talks and renewed ...

Wall Street's major averages plummeted on Friday after Israel and Iran traded missile strikes and stoked concerns of an ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Recursion Pharmaceuticals ( RXRX -5.13%) is not the most famous artificial intelligence (AI) stock on the market, but the ...

Trying to choose between ACH vs wire transfer? Compare fees, speed, and security to pick the best option for your financial ...

Gov. Josh Shapiro’s administration plans to save money by cutting poor patients’ access to expensive weight-loss drugs like ...

Part of the appeal of amylin analogs is the potential to drive weight loss without causing the same level of tolerability problems as GLP-1 receptor agonists. Lilly reported relatively low rates of ...

SOUTHLAKE, TX AND NEW YORK, NY / ACCESS Newswire / June 16, 2025 / Allied OMS, a doctor-led management services organization ...

Associate professor Kristiina Tammimies conduct world leading research on the medical, genetic, and molecular underpinnings ...

With many different species entering torpor for a variety of reasons, scientists are looking to their sleepy secrets for ways ...